KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) EBIT: 2017-2025

Historic EBIT for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to -$136.3 million.

  • Twist Bioscience's EBIT rose 16.95% to -$29.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$136.3 million, marking a year-over-year increase of 38.30%. This contributed to the annual value of -$136.3 million for FY2025, which is 38.30% up from last year.
  • Twist Bioscience's EBIT amounted to -$136.3 million in FY2025, which was up 38.30% from -$220.8 million recorded in FY2024.
  • Twist Bioscience's EBIT's 5-year high stood at -$136.3 million during FY2025, with a 5-year trough of -$234.8 million in FY2022.
  • Its 3-year average for EBIT is -$191.4 million, with a median of -$217.2 million in 2023.
  • Per our database at Business Quant, Twist Bioscience's EBIT plummeted by 53.72% in 2022 and then surged by 38.30% in 2025.
  • Twist Bioscience's EBIT (Yearly) stood at -$152.7 million in 2021, then slumped by 53.72% to -$234.8 million in 2022, then grew by 7.50% to -$217.2 million in 2023, then fell by 1.69% to -$220.8 million in 2024, then skyrocketed by 38.30% to -$136.3 million in 2025.